- resources in finance

Pfizer/NYU Stern School of Business
Legal Leadership Series

Corporate Finance
Prof. Ian Giddy
New York University

Ian Giddy has taught finance at NYU, Columbia, Wharton, Chicago and in 40 countries abroad for the past three decades. He was Director of International Fixed Income Research at Drexel Burnham Lambert from 1986 to 1989. The author of more than fifty articles on international finance, he has served at the International Monetary Fund and the U.S. Treasury and has been a consultant with numerous corporations and financial institutions in the U.S. and abroad. As a banker and consultant he has been involved in the growth of the ABS market in the USA, Europe and Asia. He is the author or co-author of The International Money Market, The Handbook of International Finance, Cases in International Finance, Global Financial Markets, Asset Securitization in Asia and The Hudson River Watertrail Guide. - resources in finance

The Session

In this half-day session w
e review the key corporate finance decisions - investment, financing and risk management - that contribute to shareholder value. Running through the key computations and numbers of corporate finance, we discover the assumptions behind common models and ratios used in valuation of a company, in mergers and and other forms of corporate financial restructuring. We apply this to several case studies, revealing how a pharmaceutical firm can create value by applying these principles of risk-adjusted valuation-based investment and funding decisions.

The session will include case studies of actual coporations and their financings, as well as hands-on exercises, and, where possible, discussions of the special challenges facing a global pharmaceutical company like Pfizer.

Outline of Session



The Job of the CFO
  • Why finance matters -- and why most companies are undervalued
  • The 5 principles of corporate finance
  • The corporate value drivers, and how to change them
  • Example: Novartis
  • Measuring value: implementing the free cash flow approach
  • What "free cash flow" means
  • Valuing a company at the equity level versus whole-firm value
  • How business risk combined with financial risk influences investors' return expectations
  • Investment decision analysis
  • Acquisitions: the good, the bad and the ugly
  • Case study: "The Acquisition of Celtel." Participants evaluate the business and financial merits of an investment.


The financial markets
Notes on cost of capital and capital structure .

Case studies
Pfizer Financials

Celtel solution

Value Creation Through Corporate Financing Decisions
  • How companies are financed - and how they should be financed
  • Evaluating sources of capital for improved decision making
  • Examples: Vivendi, Novartis, Pfizer
  • Methods of effective cost analysis: how to measure the cost of debt and the cost of equity
  • The weighted-average cost of capital
  • Example: Motorola
  • Finding the optimal capital structure: debt, equity or hybrid?
  • Case study: "Financing Pfizer." We will estimate the effective cost of capital for Pfizer at various levels of debt, and consider how the financial structure fits the company's business strategy. | | | | contact
Copyright ©2005 Ian Giddy. All rights reserved.